🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for Persistent, Recurrent, or Metastatic Cervical Cancer

A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer NCT05798819Phase 31 site📍 Shanghai Guangzhou Gloria Biosciences Co., Ltd. · Tests: GLS-010, Placebo, paclitaxel, cisplatin, carboplatin PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer NCT07472153Phase 2, Phase 31 site📍 Minsk N.N. Alexandrov National Cancer Centre · Tests: PD-1 antibody, PD-L1 antibody, Chemotherapy and bevacizumab (CT-BEV) Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer. NCT06670911Phase 21 site📍 Rio de Janeiro Instituto Nacional de Cancer, Brazil · Tests: Low-dose Pembrolizumab Plus Chemotherapy (Paclitaxel plus Carboplatin or Cisplatin) Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer NCT05817214Phase 21 site📍 Wuhan Zhongnan Hospital · Tests: Cadonilimab, Anlotinib, Granulocyte-Macrophage Colony-Stimulating Factor BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer NCT06123884Phase 2, Phase 31 site📍 Wuhan Bio-Thera Solutions · Tests: Recombinant humanized anti-PD-1 monoclonal antibody injection, Cisplatin, Bevacizumab Injection, carboplatin, Paclitaxe… Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer NCT06459687Phase 35 sites📍 Hefei📍 Beijing📍 Wuhan Lee's Pharmaceutical Limited · Tests: Socazolimab+cisplatin/carboplatin+paclitaxel+Bevacizumab, Placebo+cisplatin/carboplatin+paclitaxel+Bevacizumab A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) NCT07216703Phase 3182 sites📍 Birmingham📍 Anchorage📍 Irvine Merck Sharp & Dohme LLC · Tests: Pembrolizumab, Sacituzumab Tirumotecan, Bevacizumab, Paclitaxel, Cisplatin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy